옵션 체인은 다양한 행사가격과 만기일에 대한 N2OFF의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 N2OFF에 대한 시장 심리를 평가합니다..

N2OFF (NASDAQ:NITO) 주식, 옵션 체인

N2OFF

N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork. The Company has two reportable segments: Pathogen prevention and prolong shelf life, and the N2O emissions Global warming solutions.

N2OFF Inc

NITORI HOLDINGS CO LTD by Nitori Holdings Co., Ltd.

Nitori Holdings Co Ltd

NITORI HOLDINGS CO U/ADR by Nitori Holdings Co., Ltd.

Perplexity AI is outshining established competitors in the voice assistant market, according to the company&#8217;s CEO, as the battle for <a href="https://www.benzinga.com/markets/equities/24/08/40089426/mark-zuckerberg-aims-for-ai-assistant-dominance-over-siri-alexa-and-chatgpt-seeks-market-leaders">artificial intelligence assistant dominance intensifies</a>.
What Happened: Perplexity CEO Aravind Srinivas highlighted findings from a 9to5Mac comparison showing his company&#8217;s offering &#8220;clearly outperformed or is at parity&#8221; with Apple Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) Siri and OpenAI&#8216;s ChatGPT across most categories. 
The evaluation tested factual queries, summarization, web search, navigation, reasoning abilities and daily help functions.
The assessment found ChatGPT excelled in reasoning and contextual understanding, while Siri performed best only in system-level iOS integrations. Perplexity emerged as the most versatile option, combining web-based intelligence with limited Apple app integration.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Siri vs ChatGPT vs Perplexity: A comparison of three voice assistants on iOS by 9to5Mac. Cool idea that does a comparison of a spectrum of use cases. Tests conducted on simple quick facts, summarization, web search look up, navigation and local results, reasoning, daily help…
&mdash; Aravind Srinivas (@AravSrinivas) <a href="https://twitter.com/AravSrinivas/status/1920000406354330117?ref_src=twsrc%5Etfw">May 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/05/45246445/china-warns-us-not-to-use-coercion-and-extortion-tactics-ahead-of-first-major-trade-talks-in-geneva-says-it-will-never-accept-it-if-americans-use-dialogue-as-smokescreen">China Warns US Not To Use &#8216;Coercion And Extortion&#8217; Tactics Ahead Of Trade Talks In Geneva, Says Will &#8216;Never Accept It&#8217; If Americans Use Dialogue As &#8216;Smokescreen&#8217;</a>
Why It Matters: This comparison comes amid Apple&#8217;s <a href="https://www.benzinga.com/25/03/44345486/apple-scrambles-to-fix-siris-ugly-and-embarrassing-ai-failures-after-public-missteptop-executive-admits-marketing-it-too-soon-made-things-worse">reported struggles with AI development</a>. Bloomberg recently described Apple&#8217;s AI efforts as facing a &#8220;crisis,&#8221; with Siri division senior director Robby Walker acknowledging &#8220;ugly and embarrassing&#8221; delays in AI features. 
Perplexity, backed by Jeff Bezos and NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), <a href="https://www.benzinga.com/markets/equities/25/03/44370200/softbank-signs-agreement-to-resell-perplexity-enterprise-pro-deploying-7000-sales-members-to-drive-adoption-in-japan">has gained momentum with recent Android launches</a> and a SoftBank Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>) partnership deploying 7,000 sales team members to drive enterprise adoption in Japan. 
Srinivas previously stated, &#8220;Perplexity will make Apple Intelligence work&#8221; when <a href="https://www.benzinga.com/25/03/44429645/perplexity-ceo-says-app-will-make-apple-intelligence-work-amid-iphone-makers-ai-challenges">responding to suggestions his startup should replace Siri</a>.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="The Best iPhone Voice Assistant Isn't Who You Think - Siri vs GPT vs Perplexity" width="500" height="281" src="https://www.youtube.com/embed/v_Of7UBRQVY?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45242461/donald-trumps-trade-war-sparks-first-major-us-china-talks-scott-bessent-jamieson-greer-to-meet-chinese-delegation-in-geneva">Scott Bessent To Meet Chinese Officials For Crucial Trade Talks In Switzerland: Trump Administration</a></li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

Equities

News

Markets

Tech

AAPL

AMZN

GOOGL

MSFT

NVDA

SFTBY

Jeff Bezos-Backed Perplexity AI Outperforms Apple's Siri And ChatGPT In iOS Voice Assistant Comparison, CEO Aravind Srinivas Says

Tempus AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), a key holding in Cathie Wood's Ark Invest portfolio, reassured investors Tuesday that its major pharmaceutical contracts remain strong despite challenges in biotech funding and global tariff concerns.
What Happened: During the company's <a href="https://www.benzinga.com/general/health-care/25/05/45238450/tempus-ai-q1-earnings-revenue-beat-eps-beat-raised-fy-guidance-shares-surge">first-quarter earnings</a> call, Tempus AI's CFO Jim Rogers addressed concerns about potential risks to the company's total contract value (TCV) due to a tougher macroeconomic environment, including biotech funding slowdowns and tariff uncertainties.
He explained that Tempus works with two main groups: 19 of the top 20 large pharmaceutical companies and a few hundred smaller biotechs.
The CFO acknowledged that the biotech sector has felt the impact of weaker funding over the past two years but stressed that it makes up only a small portion of Tempus's overall business.
See Also:&nbsp;<a href="https://www.benzinga.com/25/04/45093311/not-everyone-needs-a-thousand-ai-engineers-but-for-those-who-do-zuckerberg-says-meta-will-gladly-build-it-for-a-price" target="_blank" rel="noreferrer noopener">Meta CEO Mark Zuckerberg Says AI Won't Just Be About Free Tools And Ads — Some People Will Pay A Fortune To Deploy Armies Of Digital Workers</a>
"The majority of the TCV and the revenue come from the large pharma companies that have larger R&amp;D budgets," Rogers said. "The relationships with big pharma tend to be multi-year subscriptions that are committed. And so we're delivering the data that they have agreed to license over these terms. We haven't seen a significant impact on the large pharma side."
Interestingly, Rogers added that tighter pharma budgets can benefit Tempus's data business: "When budgets tend to be flat or cut, we actually see a little bit of a benefit… because leveraging the types of data that we license folks allows them to more effectively design their trials or identify targets in a more effective way."
Why It's Important: Tempus AI posted first-quarter revenue of $255.74 million, surpassing expectations of $248.13 million.
The company, which specializes in AI-driven precision medicine and patient care, reported an adjusted loss of 24 cents per share for the quarter, smaller than the anticipated 27-cent loss, as per <a href="http://pro.benzinga.com/">Benzinga Pro</a>.
Wood's Ark Investment Management holds over 5.5 million shares of Tempus AI, as of Dec. 31, 2024.
Price Action: Tempus AI shares slipped $0.096 in pre-market trading on Wednesday, following a 3.48% decline during Tuesday's regular session.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/insights/analyst-ratings/25/04/44976660/beyond-the-numbers-9-analysts-discuss-tempus-ai-stock" target="_blank" rel="noreferrer noopener">Beyond The Numbers: 9 Analysts Discuss Tempus AI Stock</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with&nbsp;the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was&nbsp;reviewed and published by Benzinga editors.
Photo courtesy: Piotr Swat / Shutterstock.com

Cathie Wood-Backed Tempus AI Says Pharma Contracts Solid Despite Biotech Funding Challenges, Tariff Pressures

Earnings

MAGN

Magnera Q4 EPS $(1.15) Down From $0.44 YoY, Sales $824.00M Up From $558.00M YoY

The President Donald Trump administration has shuttered a key federal advisory committee responsible for infection control standards in U.S. healthcare facilities, with the termination already in effect for over a month before members were notified, according to Centers for Disease Control and Prevention documents.
What Happened: The Healthcare Infection Control Practices Advisory Committee, which established national guidelines for hand-washing, mask-wearing and patient isolation protocols followed by most American hospitals, was terminated March 31, according to a CDC letter <a href="https://www.nbcnews.com/health/health-news/trump-administration-shut-cdcs-infection-control-committee-rcna205209?ref=biztoc.com">reviewed</a> by NBC News. Members said they were only informed of the decision during a virtual meeting on Friday.
The committee&#8217;s termination aligns with Trump&#8217;s <a href="https://www.benzinga.com/news/25/02/43871609/trumps-federal-workforce-downsizing-plan-gets-green-light-from-judge-appeal-by-unions-dismissed">executive order calling for federal workforce reductions</a>. The CDC and Department of Health and Human Services have not responded to requests for comment.
Four professional societies had previously urged Health and Human Services Secretary Robert F. Kennedy Jr. to preserve the committee amid widespread cuts to federal health agencies, according to a March 26 letter, the NBC News report noted.
Dr. Anurag Malani, an Infectious Diseases Society of America fellow who joined HICPAC in January, noted the committee was close to finalizing updated airborne pathogen guidelines—the first revision since 2007—which incorporated pandemic lessons.
See Also: <a href="https://www.benzinga.com/25/05/45242461/donald-trumps-trade-war-sparks-first-major-us-china-talks-scott-bessent-jamieson-greer-to-meet-chinese-delegation-in-geneva">Scott Bessent To Meet Chinese Officials For Crucial Trade Talks In Switzerland: Trump Administration</a>
Why It Matters: The committee&#8217;s dissolution comes amid <a href="https://www.benzinga.com/general/health-care/25/02/43598644/deadly-bird-flu-strain-detected-in-nevada-man-4-stocks-to-watch">concerning public health developments</a>, including the CDC&#8217;s report of the highest tuberculosis caseload in a decade and a record 216 pediatric flu deaths this season—the most since the 2009-2010 H1N1 pandemic.
According to the CDC&#8217;s termination letter, HICPAC made 540 recommendations during its three-decade existence, with 90% fully implemented nationwide.
Several of the committee&#8217;s web pages have been archived, according to the report, indicating they will no longer be updated. Members express concern that critical guidelines will stagnate despite evolving scientific research and emerging threats from drug-resistant organisms.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45245680/trump-to-reportedly-lower-china-tariffs-to-60-in-coming-weeks-predicts-investment-strategist-could-be-the-last-big-upside-catalyst-for-a-while">Trump May Lower China Tariffs To 60% In Coming Weeks, Says Piper Sandler Investment Strategist: &#8216;&#8230;Could Be The Last Big Upside Catalyst For A While&#8217;</a></li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

Government

Health Care

Trump Administration Quietly Disbands Key Infection Control Committee Weeks Before Notifying Members, Halting Updates To National Health Guidelines Amid Rising Disease Threats

As top officials from the U.S. and China prepare for the <a href="https://www.benzinga.com/25/05/45242461/donald-trumps-trade-war-sparks-first-major-us-china-talks-scott-bessent-jamieson-greer-to-meet-chinese-delegation-in-geneva">first major face-to-face negotiations</a> amid the ongoing trade war this weekend in Geneva, Beijing has warned against any attempt to use dialogue as a tool of "coercion and extortion."
What Happened: U.S. Treasury Secretary Scott Bessent and Trade Representative Jamieson Greer will meet China's Vice-Premier He Lifeng from May 9 to 12, the Trump administration announced this week.
After confirming the upcoming talks, China's commerce ministry issued a separate statement to stress that Beijing agreed to the discussions only after "taking into full account global expectations, China's interests, and the appeals of U.S. industries and consumers."
See Also: <a href="https://www.benzinga.com/25/05/45231772/lower-demand-in-china-drags-philips-q1-sales-cuts-2025-profitability-target-on-potential-trump-tariff-impact">Lower Demand In China Disrupts Philips Q1 Sales, Cuts 2025 Profitability Target On Potential Tariff Impact</a>
Why It Matters: The statement warned that if the U.S. uses dialogue "as a tactic for further coercion," China will not bow down.
"If the US says one thing but does another, or even uses talks as a smokescreen to continue coercion and extortion, China will never accept it, nor will it compromise its principles or sacrifice international fairness and justice just to reach any agreement," the statement added, according <a href="https://www.scmp.com/news/china/diplomacy/article/3309333/top-us-china-officials-meet-switzerland-discuss-trade-washington-says?module=top_story&amp;pgtype=homepage">to</a> the South China Morning Post.
The meeting could emerge as a turning point in a tense trade landscape, with the U.S. slapping tariffs as high as 145% on Chinese imports and Beijing retaliating with 125% duties on American goods.
A <a href="https://www.benzinga.com/markets/25/05/45185792/young-americans-express-discontent-over-trumps-china-tariffs">recent poll</a> indicates that the trade war has impacted President Donald Trump&#8216;s approval ratings among young Americans who are dissatisfied with rising prices brought forth by tariffs.
Earlier this week, Billionaire hedge fund manager Bill Ackman shared his belief that the <a href="https://www.benzinga.com/news/global/25/05/45215257/bill-ackman-calls-tariffs-a-one-time-reset-warns-prolonged-china-fight-could-drag-market-slump-to-q2">U.S. trade dispute will ease soon</a>, calling the tariffs "a one-time reset," not a trigger for sustained inflation.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/05/45213125/bill-ackman-says-inflation-has-largely-been-wrung-out-pushes-for-temporary-pause-on-china-tariffs-to-shield-us-businesses">Bill Ackman Says Inflation Has &#8216;Largely Been Wrung Out,&#8217; Pushes For Temporary Pause On China Tariffs To Shield US Businesses</a></li>
</ul>
Photo courtesy: Shutterstock

Global

China Warns US Not To Use 'Coercion And Extortion' Tactics Ahead Of Trade Talks In Geneva, Says Will 'Never Accept It' If Americans Use Dialogue As 'Smokescreen'

Macro Economic Events

Econ #s

Economics

U.K. Construction Purchasing Managers Index For April 46.6 Vs. 46.0 Est.; 46.4 Prior

Piper Sandler analyst Arvind Ramnani maintains Intapp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTA#NASDAQ">INTA</a>) with a Overweight and lowers the price target from $71 to $70.

Price Target

Analyst Ratings

INTA

Piper Sandler Maintains Overweight on Intapp, Lowers Price Target to $70

Piper Sandler analyst Brent Bracelin maintains BlackLine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BL#NASDAQ">BL</a>) with a Neutral and raises the price target from $46 to $50.

Piper Sandler Maintains Neutral on BlackLine, Raises Price Target to $50

Amazon&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) has revealed a revolutionary robot, Vulcan, which boasts a sense of touch, enabling it to manage approximately 75% of items in Amazon&#8217;s warehouses.
What Happened: As per&nbsp;Amazon&#8217;s announcement&nbsp;on Wednesday, Vulcan is set to be introduced at the company&#8217;s &#8220;Delivering the Future&#8221; event in Dortmund, Germany. The groundbreaking robot is set to be globally deployed in the coming years, playing a pivotal role in the online retail behemoth&#8217;s operations. 
According to Aaron Parness,&nbsp;Amazon&#8217;s&nbsp;director of robotics, Vulcan represents a &#8220;fundamental leap forward in robotics.&#8221; The robot will use AI to recognize objects through touch, assessing which ones it can handle and determining the most effective way to pick them up.
Vulcan will work in conjunction with human employees, stowing&nbsp;items on the upper and&nbsp;lower levels of shelving units. This will reduce the need for human workers to frequently use ladders or bend during their work.
Jeff Bezos&#8216;s Amazon also plans to implement technology that uses machine learning and automation to create custom packaging, reducing waste. This technology will be installed in several European countries&nbsp;by the end of this&nbsp;year, with more installations planned by 2027.
SEE ALSO:&nbsp;<a href="https://benzinga.com/tech/25/05/45213809/teslas-elon-musk-says-manually-driven-cars-will-be-unusual-in-the-future-shares-updates-on-spacex-neuralink" target="_blank" rel="noreferrer noopener">Tesla&#8217;s Elon Musk Says Manually-Driven Cars Will Be &#8216;Unusual&#8217; In The Future, Shares Updates On SpaceX, Neuralink</a>
Why It Matters: The unveiling of Vulcan comes amidst a growing trend of AI and robotics integration in various industries. Earlier this year, tech giants&nbsp;Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)&nbsp;were reported to be in a race to develop <a href="https://www.benzinga.com/tech/25/02/43759759/apple-and-meta-in-race-to-develop-ai-powered-humanoid-robots">AI-powered humanoid</a> robots. Similarly,&nbsp;NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)&nbsp;introduced new AI and <a href="https://www.benzinga.com/news/large-cap/25/03/44396572/nvidia-introduces-new-ai-and-robotics-tools-at-gtc-powering-the-future-of-technology">robotics tools</a> at the GTC event, indicating a future powered by advanced technology.
However, the rise of AI and robotics has also raised concerns about job security. in 2023, economists at Goldman Sachs projected that by 2030, generative AI could automate up to 300 million jobs globally, with many additional roles undergoing significant transformation, reported The Guardian. Meanwhile, <a href="https://www.benzinga.com/news/25/04/44757196/bernie-sanders-warns-the-job-you-have-today-aint-going-to-be-here-in-10-or-15-years-as-ai-and-robotics-threaten-us-workforce">Sen. Bernie Sanders</a> has warned American workers about significant changes in the job market due to AI and robotics.
Despite concerns about job losses due to increased automation, Tye Brady, the chief technologist of robotics at Amazon, told The Guardian that robots are there to &#8220;amplify the human potential&#8221; and enhance safety, not to entirely replace human workers. "People will always be part of the equation," asserted Brady.
Amazon holds a Growth rating of 94.95% and a quality rating of 74.33%, according to&nbsp;<a href="https://www.benzinga.com/quote/AMZN" target="_blank" rel="noreferrer noopener">Benzinga&#8217;s Proprietary Edge Rankings</a>. For an in-depth report on more stocks and insights into growth opportunities,&nbsp;<a href="https://www.benzinga.com/screener/top-momentum-stocks" target="_blank" rel="noreferrer noopener">sign</a>&nbsp;<a href="https://www.benzinga.com/screener/top-momentum-stocks" target="_blank" rel="noreferrer noopener">up for Benzinga Edge.</a>
Shares of Amazon declined nearly 16% on a year-to-date basis.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/05/45233324/dogecoin-teases-diamond-bottom-reversal-is-a-breakout-imminent" target="_blank" rel="noreferrer noopener">Dogecoin Teases &#8216;Diamond Bottom&#8217; Reversal: Is A Breakout Imminent? &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Amazon Unveils Revolutionary Robot 'Vulcan' With Sense Of Touch To Handle 75% Of The Warehouse Items: 'People Will Always Be Part Of The Equation'

The estimated impact of a 10% tariff on our sales to the U.S. in the second half of the year would be less than 1% of our expected product revenues in 2025, and these cost would not be paid by Alvotech. Looking beyond 2025, given anticipated product launches and increased sales, we estimate that the impact would still constitute a low single digit percentage of Alvotech's anticipated total product revenues.

ALVO

Alvotech Expects Minimal Impact From Potential U.S. Tariffs, With Less Than 1% Effect On 2025 Product Revenues

Economist Peter Schiff called Treasury Secretary Scott Bessent "a very smart man" after a viral hearing clip showed the Cabinet official stumbling over a simple question about who ultimately pays U.S. tariffs.
What Happened: "Our Treasury Secretary Scott Bessent is a very smart man. He's not the blubbering idiot shown in this clip … He is stammering because he is struggling to formulate a BS explanation," Schiff wrote on X.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Our Treasury Secretary Scott Bessent is a very smart man. He&#39;s not the blubbering idiot shown in this clip. The reason he can&#39;t answer the simple question &quot;who pays tariffs&quot; is because he knows the answer. He is stammering because he is struggling to formulate a BS explanation. <a href="https://t.co/5lN3zxRtCY">pic.twitter.com/5lN3zxRtCY</a>
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1919884142730154311?ref_src=twsrc%5Etfw">May 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
During Tuesday's House Appropriations session, Rep. Mark Pocan repeatedly asked, "Who pays tariffs, Mr. Secretary?" Bessent replied haltingly, calling the query "very complicated," before Pocan reclaimed his time. The stumble lit up social media because orthodox economics says tariffs are levied on U.S. importers, who often pass the cost to consumers through higher prices.
Bessent has been the public face of President Donald Trump's <a href="https://www.benzinga.com/25/04/44720006/markets-take-off-as-trump-announces-90-day-tariff-pause-for-non-retaliating-nations-slaps-china-with-125-duty">125% levy</a> on Chinese goods, a policy roll‑out crafted alongside Elon Musk's Department of Government Efficiency (DOGE) to curb the deficit.
See also: <a href="https://www.benzinga.com/25/05/45242461/donald-trumps-trade-war-sparks-first-major-us-china-talks-scott-bessent-jamieson-greer-to-meet-chinese-delegation-in-geneva">Scott Bessent To Meet Chinese Officials For Crucial Trade Talks In Switzerland: Trump Administration</a>
Administration talking points argue Beijing bears the burden — an assertion economists like <a href="https://www.benzinga.com/markets/bonds/25/04/44805832/peter-schiff-counters-claims-china-wont-sell-us-treasuries-fearing-strong-currency-but-a-strong-yuan-might-suit-beijing">Schiff reject</a>. By hesitating, Schiff says, Bessent "knows the answer" but could not square it with the White House narrative.
Why It Matters: Bessent told House appropriators the economy <a href="https://www.benzinga.com/government/regulations/25/05/45227387/bessent-signals-imminent-trade-deals-dismisses-recession-fears-as-stocks-rebound">remains sturdy</a>, citing stronger‑than‑expected job growth and cooling inflation as evidence that the administration's "<a href="https://www.benzinga.com/markets/equities/25/05/45187535/scott-bessent-defends-trumps-economic-agenda-as-engine-designed-to-drive-economic-growth-despite-gdp-contraction-and-falling-approval">three‑legged stool</a>" of trade, tax cuts and deregulation is working. He dismissed recession worries, predicting first‑quarter GDP revisions will come in higher and forecasting solid tax receipts thanks to AI‑driven collection gains.
Even so, Bessent urged Congress to rein in spending, noting last year's 6.7% fiscal‑deficit-to‑GDP ratio was a peacetime record. "We have set the table for a robust economy that allows Main Street to grow," he said — a view echoed by Fundstrat's Tom Lee, who called the market's recent bounce a "<a href="https://www.benzinga.com/markets/equities/25/04/45032188/tom-lee-backs-scott-bessent-white-house-put-theory-as-nasdaq-flips-from-worst-april-start-since-great-depression-to-major-comeback">White House put</a>."
Image via Shutterstock
Read next: <a href="https://www.benzinga.com/25/05/45245315/trade-war-will-not-impact-growth-or-earnings-ahead-says-expert-as-china-us-hint-at-initiating-negotiations">Trade War Will Not Impact &#8216;Growth Or Earnings Ahead,&#8217; Says Expert As China-US Hint At Initiating Negotiations</a>

Regulations

Peter Schiff Says Scott Bessent 'Knows The Answer' To Congress' 'Who Pays Tariffs' Question, Calls Treasury Chief 'A Very Smart Man'

Piper Sandler analyst Brent Bracelin maintains Klaviyo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVYO#NYSE">KVYO</a>) with a Overweight and raises the price target from $35 to $40.

KVYO

Piper Sandler Maintains Overweight on Klaviyo, Raises Price Target to $40

Piper Sandler analyst Arvind Ramnani maintains CCC Intelligent Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCCS#NASDAQ">CCCS</a>) with a Neutral and lowers the price target from $11 to $9.

CCCS

Piper Sandler Maintains Neutral on CCC Intelligent Solutions, Lowers Price Target to $9

Shares of Porch Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCH#NASDAQ">PRCH</a>) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and raised its FY25 sales <a href="https://www.benzinga.com/quote/PRCH/earnings">guidance above estimates</a>.
Porch Group reported quarterly earnings of 8 cents per share which beat the analyst consensus estimate of a loss of 12 cents per share. The company reported quarterly sales of $104.75 million which beat the analyst consensus estimate of $79.44 million.
Porch Group shares jumped 21.4% to $7.70 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Magic Empire Global Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEGL#NASDAQ">MEGL</a>) rose 77.3% to $2.11 in pre-market trading.</li>
<li>CN Energy Group. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNEY#NASDAQ">CNEY</a>) surged 68.4% to $0.2730 in pre-market trading after jumping around 8% on Tuesday.</li>
<li>NetClass Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) gained 51.5% to $50.00 in pre-market trading after jumping over 162% on Tuesday.</li>
<li>Freight Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>) jumped 29.7% to $1.79 in pre-market trading after falling 5% on Tuesday.</li>
<li>IT Tech Packaging, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITP#NYSE">ITP</a>) gained 28.3% to $0.3280 in pre-market trading.</li>
<li>CuriosityStream Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURI#NASDAQ">CURI</a>) surged 24.2% to $4.10 in pre-market trading after the company reported better-than-expected first-quarter financial results and issued second-quarter sales guidance above estimates.</li>
<li>AvidXchange Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDX#NASDAQ">AVDX</a>) gained 19.3% to $9.78 in pre-market trading after the company announced it entered into a definitive agreement to be acquired by TPG in partnership with Corpay for a valuation of $2.2 billion.</li>
<li>Cantor Equity Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEP#NASDAQ">CEP</a>) climbed 18% to $34.57 in pre-market trading after dipping 14% on Tuesday.</li>
<li>Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) gained 7.9% to $71.50 in pre-market trading following first-quarter earnings.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Vast Renewables Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) shares dipped 62.5% to $0.1402 in pre-market trading after the company announced it voluntarily delisted from the Nasdaq.</li>
<li>WW International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) shares fell 46.8% to $0.42 in pre-market trading after the company missed its first-quarter adjusted EPS estimate and announced it will not be providing FY25 guidance.</li>
<li>FOXO Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>) shares fell 37.8% to $1.00 in pre-market trading. FOXO Technologies shares jumped 153% on Tuesday after the company announced that its Myrtle recovery centers subsidiary has seen over 400 patients since August 2023.</li>
<li>Vestis Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) fell 25.7% to $6.47 in pre-market trading after the company reported worse-than-expected quarterly financial results.</li>
<li>AIFU Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIFU#NASDAQ">AIFU</a>) declined 23.6% to $0.1719 in pre-market trading after jumping 82% on Tuesday.</li>
<li>Sarepta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) shares tumbled 20.6% to $37.10 in pre-market trading after the company reported a first-quarter adjusted EPS miss.</li>
<li>Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) fell 16.2% to $43.09 in pre-market trading after the company issued second-quarter sales guidance below estimates.</li>
<li>Lixiang Education Holding Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) dipped 14.1% to $3.00 in pre-market trading after jumping 69% on Tuesday.</li>
<li>Revolve Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) fell 10.8% to $16.90 in today's pre-market trading after the company reported downbeat quarterly sales.</li>
<li>RXO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RXO#NYSE">RXO</a>) fell 7.6% to $12.70 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45219636/top-2-energy-stocks-that-are-ticking-portfolio-bombs">Top 2 Energy Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Movers

Trading Ideas

AIFU

AVDX

CNEY

CURI

FOXO

FRGT

LXEH

MEGL

NTCL

PRCH

RVLV

SRPT

UPST

VSTE

VSTS

Why Porch Group Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket

ProFrac Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACDC#NASDAQ">ACDC</a>) reported quarterly sales of $600.30 million which beat the analyst consensus estimate of $502.39 million by 19.49 percent. This is a 3.23 percent increase over sales of $581.50 million the same period last year.

ACDC

ProFrac Holding Q1 Sales $600.30M Beat $502.39M Estimate, Net loss $15M

Tempus AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) during the first quarter secured a multi-million dollar deal to build &#8220;the world&#8217;s largest foundation model for oncology.&#8221;
What Happened: During its <a href="https://benzinga.com/general/health-care/25/05/45238450/tempus-ai-q1-earnings-revenue-beat-eps-beat-raised-fy-guidance-shares-surge">first-quarter earnings</a> call on Tuesday, Tempus shed light on its new $200 million, three-year data and modeling license agreement with AstraZeneca PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) and Pathos AI, aimed at developing a foundational model to support diagnostics and drug discovery in oncology.
&#8220;And this is big for a few reasons,&#8221; said Tempus CEO Eric Lefkofsky. <a href="https://www.benzinga.com/news/contracts/25/04/44960263/tempus-ai-stock-is-ripping-higher-wednesday-whats-fueling-the-move">This deal</a> brings the company's total remaining contract value to $1 billion and provides access to more than 300 petabytes of rich multimodal data linked to outcomes. Most importantly, Lefkofsky added, a substantial portion of the computing costs will be covered by AstraZeneca and Pathos AI.
See More: <a href="https://www.benzinga.com/general/health-care/25/05/45245367/novo-nordisks-weight-loss-blockbuster-faces-setback-from-us-compounding-surge-forecast-trimmed">Novo Nordisk&#8217;s Weight Loss Blockbuster Faces Setback From US Compounding Surge, Forecast Trimmed</a>
Lefkofsky says that the model is expected to be completed within 9 to 12 months, following which, each party will get a copy, &#8220;AZ [AstraZeneca] and Pathos to advance their drug discovery efforts and Tempus to advance its diagnostic and data products,&#8221; he says.
Lefkofsky also emphasized that the agreement is non-exclusive, allowing Tempus to license its data and collaborate on model development with other partners in the future. &#8220;We can essentially license data and build models with others, and we hope to do so,&#8221; he said, underscoring the broader strategic value of the deal.
Why It Matters: Tempus shares have been popular among retail investors ever since Former House Speaker Nancy Pelosi <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43131818/whats-going-on-with-tempus-ai-shares-wednesday">disclosed her position</a> in the company, early this year. 
There has also been a big <a href="https://benzinga.com/25/02/43805475/big-bets-on-ai-powered-precision-medicine-major-funds-from-ark-and-jpmorgan-to-blackrock-and-citadel-add-tempus-ai-to-their-portfolio">surge in institutional holdings</a> in recent months, with the likes of JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), BlackRock Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>), and Cathie Wood&#8217;s Ark Invest all scooping up its shares. 
The company reported $255.76 million in revenue <a href="https://benzinga.com/general/health-care/25/05/45238450/tempus-ai-q1-earnings-revenue-beat-eps-beat-raised-fy-guidance-shares-surge">during the first quarter</a>, up 75.4% YoY, and ahead of consensus estimates at $248.13 million. It posted a loss of $0.24 per share, beating analyst estimates forecasting a loss of $0.27 per share. 
Price Action: Tempus shares were down 3.48% on Tuesday, and it is currently down another 1.72% after hours.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="802" height="214" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07043346/Screenshot-2025-05-07-at-2.03.35-PM.png" alt="" class="wp-image-905084" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07043346/Screenshot-2025-05-07-at-2.03.35-PM.png 802w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07043346/Screenshot-2025-05-07-at-2.03.35-PM-300x80.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07043346/Screenshot-2025-05-07-at-2.03.35-PM-768x205.png 768w" sizes="(max-width: 802px) 100vw, 802px" /></figure>
The stock has a favorable price trend in the short, medium, and long term according to Benzinga&#8217;s Edge Stock Rankings. For more insights, sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge</a>.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45245680/trump-to-reportedly-lower-china-tariffs-to-60-in-coming-weeks-predicts-investment-strategist-could-be-the-last-big-upside-catalyst-for-a-while">Trump May Lower China Tariffs To 60% In Coming Weeks, Says Piper Sandler Investment Strategist: &#8216;&#8230;Could Be The Last Big Upside Catalyst For A While&#8217;</a></li>
</ul>
Photo courtesy: Piotr Swat / Shutterstock.com

Tempus AI Strikes $200M Deal With AstraZeneca, Pathos To Build World's Largest Oncology Model

Following Tuesday&#8217;s uptick, cryptocurrency bookmakers sharply increased their odds of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) recovering the critical $100,000 milestone this month.
What happened: The odds hit <a href="https://polymarket.com/event/what-price-will-bitcoin-hit-in-may?tid=1746601325983">83%</a> overnight Tuesday before falling to 76% as of this writing on Polymarket, a decentralized prediction platform. The probability jumped by 16 percentage points in the last 24 hours.
The $100,000 target was the hot pick among bettors, as Bitcoin was only 3% shy of the critical mark at the time of writing.
Punters predicted a 44% likelihood of BTC rising to $105,000 during the month, while the odds of a rise to $110,000 were only 21%.&nbsp;
Note that Polymarket, which operates on the Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">POL</a>) blockchain and allows users to place bets using cryptocurrencies, is <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44185814/polymarket-ceo-who-was-raided-by-the-fbi-on-allegations-of-regulatory-violations-gets-invited-to-white-house-crypto-summit">unavailable to U.S. residents due to regulatory restrictions</a>.
See Also:<a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock"> </a><a href="https://www.benzinga.com/25/05/45213365/maxine-waters-to-obstruct-cryptocurrency-hearing-plans-shadow-hearing-instead">Maxine Waters Plans Walkout From Crypto Hearing, Will Host &#8216;Shadow Hearing&#8217; Opposing Trump Family Ventures: Report</a>
Why It Matters: The surge in bets <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45242697/bitcoin-ethereum-dogecoin-spike-as-scott-bessents-gears-up-for-trade-talks-with-china-key-btc-stakeholders-moving-in-the-right-direction-towards-100000-target-says-ana">follows a sharp spike</a> in the cryptocurrency market overnight, which sent Bitcoin back above $97,000.
Investors reacted to news that Treasury Secretary Scott Bessent will meet Chinese officials for trade talks, stoking optimism <a href="https://www.benzinga.com/markets/equities/25/05/45204252/is-the-us-already-in-a-recession-we-think-so">amid macroeconomic uncertainty</a>.
Price Action:&nbsp; At the time of writing, BTC was exchanging hands at $96,666.47, up 2.42% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. The coin has gained 24.80% over the month.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45214067/two-dormant-bitcoin-whales-move-325-million-after-a-decade-whats-going-on">Two Dormant Bitcoin Whales Move $325 Million After A Decade: What&#8217;s Going On?</a></li>
</ul>
Photo Courtesy: creativeneko on Shutterstock.com

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$POL

Bitcoin To Hit $100,000 Soon? Polymarket Bettors Are Putting Big Money On It

The Donald Trump administration is planning to terminate the Energy Star program, which certifies energy-efficient home appliances.
Launched in 1992, it has helped American businesses and families save more than $500 billion in energy costs and reduce emissions.
What Happened: At an internal meeting at the Environmental Protection Agency (EPA) on Monday, officials said that the agency's Office of Atmospheric Protection would be shut down and the Energy Star program cancelled.
Although a confirmation of the shutdown was not issued directly, a spokesperson <a href="https://edition.cnn.com/2025/05/06/climate/energy-star-trump">told</a> CNN that these moves will "better advance the agency's core mission while Powering the Great American Comeback."
See Also: <a href="https://www.benzinga.com/news/25/05/45243396/elon-musk-wants-his-legacy-to-be-advancing-civilization-says-without-truth-seeking-ai-the-future-cou">Elon Musk Wants His Legacy To Be Advancing Civilization, Says Without &#8216;Truth-Seeking AI,&#8217; The Future Could Be &#8216;Dangerous&#8217;</a>
Why It Matters: The program has bipartisan appeal in Congress, but has been embroiled in political debates over environmental regulation of late.
Last month, Trump signed an executive order lifting restrictions on water pressure in showerheads. The termination of the Energy Star program, along with the overturning of other Biden-era climate policies by the EPA, has raised alarms.
Paula Glover, president of the nonprofit coalition Alliance to Save Energy, also pointed out the impact on household spending. "For just $32 million a year, Energy Star helps American families save over $40 billion in annual energy costs. That's a return of $350 for every federal dollar invested", she told CNN.
The latest move follows a long line of policy shifts that are likely to have major impacts on how the US tackles climate change, such as <a href="https://www.benzinga.com/25/01/43087966/trump-signs-orders-to-take-us-out-of-paris-climate-agreement-calls-the-deal-one-sided-and-unfair">withdrawing from the Paris climate agreement</a> and <a href="https://www.benzinga.com/markets/25/04/44882365/trumps-energy-department-mulls-cutting-billions-in-clean-energy-funds-threatening-exxon-occidental-projects">proposals to curb spending on clean energy projects</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/05/45216185/bill-gates-says-trumps-climate-rollbacks-may-have-slowed-progress-but-microsoft-co-founder-doesnt-think-thats-a-permanent-thing-as-americas-commitment-to-clean-energy">Bill Gates Says Trump&#8217;s Climate Rollbacks May Have Slowed Progress, But Microsoft Co-Founder Doesn&#8217;t Think &#8216;That&#8217;s a Permanent Thing&#8217;</a></li>
</ul>
Photo courtesy: T. Schneider / Shutterstock.com

Politics

Trump Administration Plans To End Energy Star Program That Helped Americans Save $500 Billion In Energy Costs: Report

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is offering a free 1-year trial for its Supervised Full Self-Driving Technology to select Cybertruck owners.
What Happened: Some owners reported receiving an email from Tesla that shared details about the offer. Tesla influencer Sawyer Merritt took to social media on the platform X on Wednesday to share the update.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">NEWS: Tesla is offering some Cybertruck owners a free 1-year trial of FSD (Supervised). <a href="https://t.co/xJUP8rCPY8">pic.twitter.com/xJUP8rCPY8</a>
&mdash; Sawyer Merritt (@SawyerMerritt) <a href="https://twitter.com/SawyerMerritt/status/1919945063322550598?ref_src=twsrc%5Etfw">May 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
"As a thank you for being an early Cybertruck adopter, we are offering you a free, 1-year trial of Full Self-Driving (Supervised)," the email said.
Tesla did not immediately respond to<a href="http://pro.benzinga.com"> Benzinga&#8217;s</a> request for comment.
The email also states that to claim the offer, eligible customers would need to subscribe to the service by June 6, 2025. Tesla also says that Autosteer won't be available for the Cybertruck outside of Supervised FSD.
Why It Matters: News of the offer comes in when Tesla has been grappling with <a href="https://www.benzinga.com/tech/25/04/44857987/tesla-experiences-151-decline-in-new-vehicle-registrations-in-california-report">poor sales figures</a> both in the U.S. as well as in <a href="https://www.benzinga.com/markets/25/05/45220631/tesla-new-car-sales-hit-2-year-low-in-uk-germany-as-european-woes-continue">regions like Europe</a>. Elon Musk's EV giant also experienced a 71% plunge in YoY profits.
Interestingly, Tesla is reportedly sitting on<a href="https://www.benzinga.com/markets/25/05/45216453/tesla-has-over-10000-units-of-unsold-cybertrucks-in-its-us-inventory-amid-poor-sales-report"> thousands of unsold Cybertruck</a> units in its U.S. inventory, even as the company <a href="https://www.benzinga.com/25/04/44919745/tesla-shifts-cybertruck-marketing-strategy-to-appeal-to-traditional-pick-up-truck-customers-amid-poor-sales">pivoted its marketing strategy</a> for the product to focus on its ruggedness as well as position it as a working man's truck.
Elsewhere, Musk reiterated his optimism for Tesla's self-driving technology and said that<a href="https://www.benzinga.com/tech/25/05/45213809/teslas-elon-musk-says-manually-driven-cars-will-be-unusual-in-the-future-shares-updates-on-spacex-neuralink"> manually driven cars</a> would become "unusual" in the future. He also said that the company will release Unsupervised FSD soon.
Price Action: TSLA is currently $278.60, gaining 1.22% in pre-market trading, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link</a>.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45244989/lucid-group-q1-2025-earnings-tesla-rival-announces-58-increase-in-deliveries-plans-to-introduce-a-mid-size-platform-in-2026">Tesla-Rival Lucid Announces 58% Increase In Deliveries, Plans To Introduce Mid-Size Platform In 2026</a></li>
</ul>
Photo courtesy: Jonathan Weiss / Shutterstock.com

TSLA

Tesla Offers Free 1-Year Supervised FSD Trial To Select Cybertruck Owners Amid Elon Musk's Self Driving Push

ACAD

ACRE

ACVA

ADMA

ADNT

ADTN

AIRG

ALNT

ALTG

ALTO

AMPH

AMPL

AMRK

AMRN

AOSL

APLS

ARIS

ARMN

ASLE

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AXON

AXTA

AZTA

BAND

BBDO

BBGI

BBSI

BGSF

Brighthouse Financial, Inc. - Common Stock

BLBD

BLMN

BLZE

BMBL

BRKR

BROS

BTMD

BXSL

BYND

CAPL

CCSI

CDLX

CENT

CENTA

CENX

CEVA

CIVI

CMTG

CNDT

COHR

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRNC

CRNT

CSGS

CSTE

CTVA

CVNA

CYRX

Earnings Scheduled For May 7, 2025

Press Releases

N2OFF: Save Foods Ltd. (100%) Wins Patent Opposition Filed by ECOLAB in Europe

N2OFF and Solterra Join Forces to Exclusively Co-Develop the Solar PV Market in Albania

N2OFF and Solterra Unite to Pioneer Solar PV Development in Albania

N2OFF and Solterra Announce the Closing of a Definitive Agreement to Develop 196 MWp Battery Storage Projects in Italy

N2OFF Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard To Treat Cancers

Contracts

SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers

N2OFF Establishes a US Subsidiary for Its Solar PV Operations

N2OFF Secures Definitive Agreement to Commercialize 196 MWp Battery Storage Projects

N2OFF Signs Non-Binding LOI for Potential 380MW Battery Energy Storage Projects

N2OFF Announces Potential to Maximize Investment Opportunity Following New Regulation in Germany

NITO

SPRC

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions

CF Industries Holdings, Inc. Common Stock

CF Industries Holdings

Corteva

Enlightify

Brazil Potash

Intrepid Potash

Mosaic

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

CVR Partners, LP Common Units representing Limited Partner Interests

CVR Partners

Comments

N2OFF

N2OFF (NITO) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌